case_images: PMC5320465_01
case_images: A) Hepatic tumor infiltrating head of the pancreas, vena cava inferior and portal vein. B) Subsequently performed CT revealed regression of the tumor. C) Tumor infiltrating head of the pancreas, vena cava inferior, portal vein and hepatic artery
case_images: WO-20-29326-g001.jpg
case_images: PMC5320465_01_WO-20-29326-g001.jpg
case_images: f0001
case_images: One month later, a hypoechogenic mass of 54 x 52 x 43 mm located in the hilus of the liver was found on control ultrasonography (USG) and computed tomography (CT) of the abdomen (Fig. 1A). Columbia Cancer Agency (BCCA) for ES/PNET - SAIME (etoposide 100 mg/m2, mesna 720 mg/m2, ifosfamide 1800 mg/m2) given for 5 consecutive days every 3 weeks alternating with SAVAC (vincristine 1.5 mg/m2, doxorubicin 75 mg/m2, cyclophosphamide 1200 mg/m2) given over one day every 3 weeks. Control CT scans after two cycles showed a 57% tumour mass reduction in the biggest dimension (Fig. 1B). Two years later, a mass of 46 x 25 mm between inferior vena cava, left liver lobe and the head of the pancreas, and a second mass of 17 x 14 mm in the common bile duct were revealed on the control CT (Fig. 1C).